Tygacil Drug Use Investigation

Trial Profile

Tygacil Drug Use Investigation

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Mar 2018

At a glance

  • Drugs Tigecycline (Primary)
  • Indications Bacterial infections
  • Focus Therapeutic Use
  • Acronyms TIGER
  • Sponsors Pfizer
  • Most Recent Events

    • 09 Mar 2018 The primary endpoint has been amended to "Number of Participants with adverse events". Hence the trial focus has changed from TU to AR.
    • 14 Jul 2017 Status changed from active, no longer recruiting to completed.
    • 07 Apr 2017 Planned End Date changed from 8 May 2017 to 1 Jun 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top